» Articles » PMID: 18001233

Larch Arabinogalactan for Dry Eye Protection and Treatment of Corneal Lesions: Investigations in Rabbits

Overview
Date 2007 Nov 16
PMID 18001233
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of the present study was to investigate the corneal protective and healing properties of arabinogalactan (AG), a natural polysaccharide present in conifers of the genus Larix (Larch). AG was tested in comparison with other two polysaccharides possessing well-established properties in the treatment of dry eye: tamarind seed polysaccharide and hyaluronic acid.

Methods: The AG formulation was subjected to the following investigations: rheologic measurements; evaluation of mucoadhesive properties by rheologic interaction with mucin; ferning test; and in vivo evaluation on rabbits, including treatment of an experimental dry eye; evaluation of the preocular retention; and evaluation of healing rate of experimental corneal wound.

Results: AG dispersions showed a newtonian nonviscous behavior, eta = 1.6 mPa . s for 10% w/w solution; it possessed good mucoadhesive properties useful for retention on the eye surface. In fact, a prolonged time of residence in rabbit eyes was ascertained using fluorescein-labeled AG. Five percent (5.0%) w/w AG exerted a good protective effect against the appearance of corneal dry spots. It also reduced significantly the healing time of an experimental corneal lesion since 27 h after the first treatment.

Conclusions: These findings suggest that AG may be a potential therapeutic product for dry eye protection and for the treatment of corneal wounds.

Citing Articles

Real-World Treatment Outcomes of an Artificial Tear Containing Arabinogalactan, Hyaluronic Acid and Trehalose Among Subjects with Dry Eye.

Bedei A, Rocha Cabrera P, Oliveira L, Castellini L, De Grazia G, Remiddi S Clin Ophthalmol. 2025; 19():83-91.

PMID: 39801568 PMC: 11724676. DOI: 10.2147/OPTH.S480668.


Polysaccharides in Ocular Drug Delivery.

Dubashynskaya N, Poshina D, Raik S, Urtti A, Skorik Y Pharmaceutics. 2019; 12(1).

PMID: 31878298 PMC: 7023054. DOI: 10.3390/pharmaceutics12010022.


Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment.

Tampucci S, Monti D, Burgalassi S, Terreni E, Zucchetti E, Baldacci F Pharmaceutics. 2018; 10(3).

PMID: 30149648 PMC: 6161197. DOI: 10.3390/pharmaceutics10030137.


A water-soluble, mucoadhesive quaternary ammonium chitosan-methyl-β-cyclodextrin conjugate forming inclusion complexes with dexamethasone.

Piras A, Zambito Y, Burgalassi S, Monti D, Tampucci S, Terreni E J Mater Sci Mater Med. 2018; 29(4):42.

PMID: 29603020 DOI: 10.1007/s10856-018-6048-2.


Arabinogalactan as active compound in the management of corneal wounds: in vitro toxicity and in vivo investigations on rabbits.

Burgalassi S, Nicosia N, Monti D, Falcone G, Boldrini E, Fabiani O Curr Eye Res. 2010; 36(1):21-8.

PMID: 21174594 PMC: 3154582. DOI: 10.3109/02713683.2010.523193.